Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma”

91 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 91 results

Testing effectiveness (Phase 2)Looking for participantsNCT07699185
What this trial is testing

Neoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tongji Hospital 336
Testing effectiveness (Phase 2)Looking for participantsNCT07457528
What this trial is testing

Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC

Who this might be right for
Resectable Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 46
Testing effectiveness (Phase 2)UnknownNCT06235918
What this trial is testing

Neoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomasResectable Head and Neck Squamous-cell Carcinoma
Xiang Lu 30
Testing effectiveness (Phase 2)UnknownNCT06130007
What this trial is testing

A Prospective, Single-arm Phase II Clinical Trial of Tislelizumab Combined With Platinum Doublet Neoadjuvant Therapy to Improve Mandibular Preservation in Resectable Locally Advanced Oral Squamous Cell Carcinoma.

Who this might be right for
Oral Squamous Cell Carcinoma
Xuekui Liu 48
Large-scale testing (Phase 3)Looking for participantsNCT05125055
What this trial is testing

Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC

Who this might be right for
Oral Squamous Cell CarcinomaNeoadjvant TherapyAnti-PD-1+1 more
Shanghai Jiao Tong University School of Medicine 80
Testing effectiveness (Phase 2)Looking for participantsNCT07381075
What this trial is testing

A Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
West China Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT05388773
What this trial is testing

Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer

Who this might be right for
Oropharynx Cancer
Heath Skinner 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07400094
What this trial is testing

Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC

Who this might be right for
Squamous Cell Carcinoma of Head and NeckLaryngeal NeoplasmsOral Cavity Neoplasm
National Medical Research Radiological Centre of the Ministry of Health of Russia 50
Testing effectiveness (Phase 2)Looking for participantsNCT06385730
What this trial is testing

Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS)

Who this might be right for
Esophageal Cancer
Shanghai Chest Hospital 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03174275
What this trial is testing

Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma

Who this might be right for
Carcinoma, Squamous CellOral CancerOropharynx Cancer+3 more
UNC Lineberger Comprehensive Cancer Center 39
Testing effectiveness (Phase 2)Looking for participantsNCT07385001
What this trial is testing

A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaIvonescimabNeoadjuvant
Tang-Du Hospital 45
Testing effectiveness (Phase 2)Ended earlyNCT02331875
What this trial is testing

Efficacy Study of Pre-operative IPH2201 in Patients With Squamous Cell Carcinoma of the Oral Cavity

Who this might be right for
Squamous Cell Carcinoma of the Oral Cavity
Innate Pharma 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT07374003
What this trial is testing

Ipromlimab and Tuvonralimab Combined With Albumin-Bound Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced, Resectable
Sun Yat-sen University 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT01898494
What this trial is testing

Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

Who this might be right for
Human Papilloma Virus InfectionStage III Squamous Cell Carcinoma of the OropharynxStage IVA Squamous Cell Carcinoma of the Oropharynx+1 more
ECOG-ACRIN Cancer Research Group 519
Testing effectiveness (Phase 2)Looking for participantsNCT07147426
What this trial is testing

Tislelizumab Combined With Chemotherapy for Different Cycles of Neoadjuvant Therapy for Locally Advanced Resectable Squamous Cell Carcinoma of the Head and Neck (NeoTempo)

Who this might be right for
Head &Amp; Neck Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 100
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07312578
What this trial is testing

Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University 48
Testing effectiveness (Phase 2)Looking for participantsNCT07162506
What this trial is testing

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 120
Not applicableLooking for participantsNCT02972372
What this trial is testing

Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer

Who this might be right for
Esophagus Cancer
The First Affiliated Hospital of Henan University of Science and Technology 196
Testing effectiveness (Phase 2)Looking for participantsNCT06869213
What this trial is testing

A Single-arm, Open, Single-center Exploratory Study of Adebrelimab (SHR-1316) in Combination With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Esophageal Squamous Carcinoma

Who this might be right for
Esophageal Cancer (EsC)
Peking University Cancer Hospital & Institute 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07678580
What this trial is testing

Neoadjuvant Short-Course Radiotherapy Plus Tislelizumab and Chemotherapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Tang-Du Hospital 50
Next Page